Milky discharge when not pregnant: the prolactin question
Evidence last assessed 2026-10-14.
In short
- What the research shows
- Milky discharge when not pregnant often points to prolactin: ask for prolactin, TSH and a pregnancy test.
- What it doesn't show
- It diagnoses nothing; bloody discharge or a new lump needs an urgent appointment.
- PMOS
- Tests and appointments
See studies and method
What the evidence says
Milky nipple discharge when you are not pregnant or breastfeeding (galactorrhoea) points at prolactin, and raised prolactin can mimic the condition: it disturbs cycles the same way while needing different treatment. The standard first step is simple and worth asking for by name: a pregnancy test, a prolactin level, and TSH.
A clinical review of galactorrhoea: rule out pregnancy first, then check a prolactin level and TSH for thyroid function. The international guideline for the condition also lists prolactin and TSH among the tests that rule out look-alikes. Headaches or changes in vision alongside it are part of what the clinician needs to hear, because persistently raised prolactin can come from the pituitary. A separate branch is not softened: discharge that is bloody or comes from a single duct on one side, or any new breast lump, needs prompt medical assessment, so ask for an urgent appointment. That is a different question from hormones, and not one to watch and wait on.
What this does not show
This points you at the right tests and the right urgency, and it diagnoses nothing: milky discharge has benign causes, medications among them, and a raised prolactin is a finding to interpret with a clinician, not a verdict. The two branches are different and stay different. For milky discharge, ask for the tests; for bloody or single-duct discharge or a new lump, ask for an urgent appointment. Some medications (certain antipsychotics, antidepressants and anti-nausea drugs) commonly raise prolactin, and that history belongs in the same conversation.
Sources, as Neta holds them
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-88. doi:10.1210/jc.2010-1692
Guideline synthesis
Huang W, Molitch ME. Evaluation and management of galactorrhea. Am Fam Physician. 2012;85(11):1073-80. Available from: https://www.aafp.org/pubs/afp/issues/2012/0601/p1073.html
marketing.learn.design.narrative_review
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-69. doi:10.1210/clinem/dgad463
Guideline synthesis
National Institute for Health and Care Excellence. Suspected cancer: recognition and referral [NG12]. London: NICE; 2015 [cited 2026 Oct 14]. Available from: https://www.nice.org.uk/guidance/ng12/chapter/recommendations-organised-by-site-of-cancer
Guideline synthesis
NHS. Breast pain [Internet]. Page last reviewed 2023 May 3 [cited 2026 Oct 14]. Available from: https://www.nhs.uk/conditions/breast-pain/
Guideline synthesis